| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017322189 |
| P356 | DOI | 10.1038/TPJ.2014.2 |
| P932 | PMC publication ID | 4111770 |
| P698 | PubMed publication ID | 24513692 |
| P5875 | ResearchGate publication ID | 260152352 |
| P50 | author | Eric Winer | Q16887072 |
| Marylyn D. Ritchie | Q18631934 | ||
| Sarah Pendergrass | Q56420611 | ||
| Mike Baldwin | Q73318307 | ||
| P2093 | author name string | M Li | |
| Y Nakamura | |||
| H L McLeod | |||
| M Kubo | |||
| M J Ratain | |||
| C A Hudis | |||
| E A Stahl | |||
| R M Plenge | |||
| L N Shulman | |||
| D L Kroetz | |||
| J S Witte | |||
| A Chhibber | |||
| H Zembutsu | |||
| J Mefford | |||
| K Owzar | |||
| P2860 | cites work | Gene ontology: tool for the unification of biology | Q23781406 |
| Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival | Q24338406 | ||
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes | Q24635938 | ||
| The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes | Q24655027 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| The Gene Ontology (GO) database and informatics resource | Q27860988 | ||
| Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother | Q28258937 | ||
| Ndel1 promotes axon regeneration via intermediate filaments | Q28574725 | ||
| GCTA: a tool for genome-wide complex trait analysis | Q29547216 | ||
| Common SNPs explain a large proportion of the heritability for human height | Q29547221 | ||
| Genotype imputation | Q29614590 | ||
| dbSNP: a database of single nucleotide polymorphisms | Q30826134 | ||
| Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study | Q33331105 | ||
| Phase I trial of taxol in patients with advanced cancer | Q33444037 | ||
| Biofilter: a knowledge-integration system for the multi-locus analysis of genome-wide association studies. | Q33810312 | ||
| Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia. | Q34135061 | ||
| Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. | Q34228079 | ||
| A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception | Q34300023 | ||
| Taxane pathway | Q34390370 | ||
| Genome-wide association studies in pharmacogenomics: successes and lessons | Q34415006 | ||
| Estimating missing heritability for disease from genome-wide association studies | Q34687621 | ||
| Paclitaxel (taxol) | Q34723890 | ||
| The impact of improved microarray coverage and larger sample sizes on future genome-wide association studies | Q34920565 | ||
| Genome partitioning of genetic variation for complex traits using common SNPs | Q34973837 | ||
| Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. | Q35063229 | ||
| Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia | Q35148088 | ||
| The identification of gene expression profiles associated with progression of human diabetic neuropathy | Q35540055 | ||
| Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. | Q35651995 | ||
| Inhibition of neurite initiation and growth by taxol | Q36210577 | ||
| The ABCB1 3435 T allele does not increase the risk of paclitaxel-induced neurotoxicity | Q36216741 | ||
| A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. | Q36243420 | ||
| Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. | Q36389193 | ||
| Peripheral neuropathy induced by microtubule-stabilizing agents. | Q36436422 | ||
| Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy. | Q36877796 | ||
| A genomic scan for age at onset of Alzheimer's disease in 437 families from the NIMH Genetic Initiative | Q37141895 | ||
| Netrins promote developmental and therapeutic angiogenesis. | Q40261184 | ||
| Neurotoxicity of Taxol. | Q40623879 | ||
| Clinical toxicities encountered with paclitaxel (Taxol). | Q40711497 | ||
| Paclitaxel-induced neuropathy | Q42277853 | ||
| Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies | Q42281607 | ||
| Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings | Q42281727 | ||
| GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients | Q43474093 | ||
| Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity | Q43496569 | ||
| Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism. | Q44337903 | ||
| Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer | Q45052168 | ||
| First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain | Q46748169 | ||
| Upregulation of Ryk expression in rat dorsal root ganglia after peripheral nerve injury | Q48936627 | ||
| Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer. | Q50526560 | ||
| Evidence for a pleiotropic QTL on chromosome 5q13 influencing both time to asthma onset and asthma score in French EGEA families | Q56893578 | ||
| APOE genotype is a risk factor for neuropathy severity in diabetic patients | Q61659518 | ||
| Nerve growth factor prevents toxic neuropathy in mice | Q67682536 | ||
| Taxol-induced neuropathy: chronic effects of local injection | Q68971631 | ||
| Taxol produces a predominantly sensory neuropathy | Q69368435 | ||
| Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy | Q71879369 | ||
| Nerve Growth Factor Attenuates Neurotoxic Effects of Taxol on Spinal Cord-Ganglion Explants from Fetal Mice | Q72529117 | ||
| HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy | Q77407915 | ||
| Erythropoietin protects sensory axons against paclitaxel-induced distal degeneration | Q79161878 | ||
| Dynamic changes in Robo2 and Slit1 expression in adult rat dorsal root ganglion and sciatic nerve after peripheral and central axonal injury | Q80274748 | ||
| Genome-wide linkage analyses of type 2 diabetes in Mexican Americans: the San Antonio Family Diabetes/Gallbladder Study | Q81118491 | ||
| Upregulations of P2X(3) and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats | Q84025952 | ||
| P433 | issue | 4 | |
| P921 | main subject | sensory peripheral neuropathy | Q18555098 |
| P304 | page(s) | 336-342 | |
| P577 | publication date | 2014-02-11 | |
| P1433 | published in | The Pharmacogenomics Journal | Q10534704 |
| P1476 | title | Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). | |
| P478 | volume | 14 |
| Q39293928 | Chemotherapy-induced peripheral neuropathy: A current review |
| Q36421901 | Chemotherapy-induced peripheral neuropathy: Current status and progress |
| Q98383559 | Chemotherapy-induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design |
| Q35796623 | Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy |
| Q47248078 | Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci |
| Q38292930 | Genomic architecture of pharmacological efficacy and adverse events |
| Q38522986 | Host Factors and Risk of Breast Cancer Recurrence: Genetic, Epigenetic and Biologic Factors and Breast Cancer Outcomes |
| Q41009010 | Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk |
| Q27314983 | Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells |
| Q48656158 | Neurotoxic mechanisms of paclitaxel are local to the distal axon and independent of transport defects |
| Q39796533 | Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy |
| Q38522970 | Symptoms: Chemotherapy-Induced Peripheral Neuropathy |
| Q45759415 | Taxane-Induced Peripheral Neurotoxicity. |
Search more.